What does dihydroberberine do for your body?

Dihydroberberine is a hydrogenated derivative of berberine that has been extensively studied in animals to evaluate its absorption, metabolism, and interactions with cellular energy pathways, with limited research in humans.

What Is Dihydroberberine and How Does It Work?

Berberine is also known as dihydroberberine (DHB or DHBBR), which is a structurally modified version of berberine. This is paralleled by its increased interest in developing ingredients, which has a close relationship to its various physicochemical and metabolic properties.

The structure of hydrogenated berberine is partially reduced from the structure of ordinary berberine; the chemical and pharmacokinetic properties also have differences.

Absorption research: Human and laboratory studies have been conducted to see how DHB is absorbed into the body and then converted to berberine and other metabolites when taken orally.

Metabolic pathway research: Experimental studies on DHB have focused on its role in energy signaling in cells, such as pathways involved in AMPK and glucose metabolism. The results of these studies are mainly mechanistic and do not give evidence of a specific consumer effect.

Dihydroberberine and Berberine Absorption

The comparison of the two does not seem to be a straightforward “strength” comparison; one of the major technical distinctions between the two is pharmacokinetics.

A pilot randomized crossover study compared the plasma levels of DHB with those of 500 mg berberine and found that different plasma levels of berberine were observed when using DHB.

Metabolite formation: A pilot study in 2024 revealed metabolite exposure was different after the DHB vs. micellar berberine formulations, suggesting that metabolites and molecular form can be different, and that this can affect metabolic exposure.

Manufacturers should not assume dose equivalence: Different doses may result in different exposures.

 

Dihydroberberine Dosage and Formulation Factors

When formulating for commercial use, dosage should not be regarded as a universal recommendation.

Published human research: 100 mg and 200 mg of DHB have been studied in human research. These are research doses and should not be assumed to be a suggested dose for use by consumers.

Assay purity: It is possible to get some reduction in the amount of carrier material needed to achieve a desired concentration of active ingredient with a higher-assay Dihydroberberine Powder.

Serving calculation: Formulators need to calculate the quantity of powder to be used based on the verified assay, target active content, serving size, and analytical potency, not just on the name of the product.

Formulation considerations: The processes of dispersion, excipient selection, and control are different for capsule, tablet, and powder blend and beverage formulations.

Dihydroberberine Powder for Supplement Formulation

For the ingredient manufacturers, the usefulness of bulk Dihydroberberine Powder is that it has a well-defined chemical specification and is easily adaptable for formulation development.

Capsules and tablets: The powder can be investigated for solid dose formulations, including the characteristics of particle size, flowability, compressibility, and uniformity of the powder.

Homogeneous distribution and accurate assay of dihydroberberine require powder blends.

Functional beverages: The dispersion, sensory properties, pH compatibility, processing temperature, and storage stability should be considered prior to commercial production.

Energy drink formulations: In the case of energy drinks with special plant-based ingredients, DHB should be evaluated as part of the entire composition of the ingredient.

Private Label: Contract manufacturers may incorporate standardized Dihydroberberine Powder into their custom formulations, in compliance with the requirements of the desired market.

 

Dihydroberberine Powder Stability and Quality Control

When you buy a botanical ingredient that is specially extracted for a specific use in commercial production, it must be stable.

Assay verification: Each batch should be verified for the content of dihydroberberine according to the specified content; the analytical method is validated.

Identification test: Chromatographic or other suitable analyses can be used to identify the DHB from similar berberine compounds.

Moisture control: Packaging must reduce moisture and environmental conditions that could impact handling of powders and packaging life.

Impurity profile: Related compounds, residual solvents, heavy metals, and microbiological parameters should be set by the manufacturers based on the intended use.

Storage conditions: Cool and dry, in good quality sealed packages, in general. Conditions based on supplier stability data.

What Current Research Says About Dihydroberberine

Scientific evidence should be divided into pharmacokinetic observations, scientific mechanisms, and practical formulation considerations.

Human pharmacokinetics: There are small human studies that suggest oral bioavailability of DHB and its metabolites in humans, but these studies are not enough to draw generalisable conclusions about human physiology.

Cellular mechanisms: AMPK, glucokinase, lipid metabolism and other biochemical pathways have been studied, but many of these studies have been carried out in experimental models.

Safety research: Preclinical toxicological research has been performed to assess the acute toxicity, genotoxicity, and repeated dose (chronic) toxicity of the ingredients and has generated useful data for the development of ingredients but cannot replace the application-specific, regulatory evaluation.

Limitations of research: There are still larger, well-controlled human studies that need to be performed to establish long-term usage, dosage-response relationships, and the clinical relevance of any observed metabolic differences.

What does dihydroberberine do for your body?

The structure of dihydroberberine is modified. The modified structure of dihydroberberine has different absorption and metabolic characteristics compared with conventional berberine; this is the main reason that dihydroberberine attracts the interest of scientists and commercialization. The conversion to berberine-related metabolites and effects on cellular metabolic pathways are currently under study, and there is limited evidence from humans. In the case of manufacturers, therefore, the best way to assess Dihydroberberine Powder is by verifying the assay, calculating the dosage, examining the formula compatibility, verifying the stability parameters, and checking the regulatory requirements, but not by the claim of physiological activity.

 

To get in touch directly, email info@scigroundbio.com, or you can complete the form found at the bottom of this web page. We are prepared to help you quickly and make sure you get a good price.

​​​​​​​

FAQ

1. What does dihydroberberine do for your body?

The absorption, metabolism, and interaction of dihydroberberine with cellular pathways that are related to energy are being studied. There is still limited evidence in humans.

2. What is the difference between dihydroberberine and berberine?

Dihydroberberine is a hydrogenated product of berberine which has different physicochemical and pharmacokinetic properties.

3. What is the studied dihydroberberine dosage?

Human research has been conducted at two study doses (100 mg and 200 mg), but such research doses should not be used as general dosage guidelines.

4. Can bulk dihydroberberine powder be used in supplements?

Yes. Can be evaluated for capsules, tablets, powder blends, and other formulations (based on the formulation testing and applicable regulations).

5. What should buyers check when sourcing dihydroberberine powder?

Specifications cover such aspects as assay, identity, related compounds, residual solvents, heavy metals, microbiological quality, packaging, storage conditions, and batch consistency.

References

1. Chang, C., Roh, Y. S., Du, M., et al. (2024). Differences in metabolite profiles of dihydroberberine and micellar berberine in Caco-2 cells and humans—A pilot study. International Journal of Molecular Sciences, 25(11), 5625.

2. Tsai, Y. C., et al. (2022). Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: A randomized, controlled, crossover pilot trial. [Journal publication indexed in PubMed].

3. Lewis, K. D., & Falk, M. (2022). Toxicological assessment of dihydroberberine. Food and Chemical Toxicology, 168, 113301.

4. Khoshandam, A., Imenshahidi, M., & Hosseinzadeh, H. (2022). Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review. Phytotherapy Research, 36(11), 4063–4079.

5. Li, X., et al. (2023). Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties. Expert Opinion on Drug Metabolism & Toxicology.